Emerging evidence indicates that glibenclamide exerts important beneficial effects in cerebral ischemia, especially in humans with large hemispheric infarctions [21,22], reaffirming a critical role for SUR1-TRPM4 channels in stroke. This evidence concerns the gene TRPM4 and brain ischemia.